{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-dyspnoea/management/symptomatic-treatment/","result":{"pageContext":{"chapter":{"id":"cdb4ccb3-9b96-5651-9950-6e2e0b8f4da0","slug":"symptomatic-treatment","fullItemName":"Scenario: Symptomatic treatment","depth":2,"htmlHeader":"<!-- begin field 8491eb1a-3be4-4296-a735-8b5a2385c058 --><h2>Scenario: Symptomatic treatment</h2><!-- end field 8491eb1a-3be4-4296-a735-8b5a2385c058 -->","summary":"Covers the management of people with dyspnoea in a palliative care setting who require treatment of symptoms.","htmlStringContent":"<!-- begin item c1eda526-8971-4f46-9e8a-bfbd99c3cd50 --><!-- begin field 5495250c-544f-478e-aab0-acbc015b15b6 --><p>From age 16 years onwards.</p><!-- end field 5495250c-544f-478e-aab0-acbc015b15b6 --><!-- end item c1eda526-8971-4f46-9e8a-bfbd99c3cd50 -->","topic":{"id":"20d4363b-caf3-55a9-beed-09266efa45f4","topicId":"73af552e-909d-456c-86d1-11f7a65040d8","topicName":"Palliative care - dyspnoea","slug":"palliative-care-dyspnoea","lastRevised":"Last revised in November 2020","chapters":[{"id":"0614f3a6-7238-5427-b059-9195b0cc2aa1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"738e7584-0909-59c3-bd54-43100aed01fe","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"ea721a0d-cda2-5620-8e3f-61e76920b9b3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"83260a2e-73f3-5abd-b049-c307d85d2cff","slug":"changes","fullItemName":"Changes"},{"id":"460710fb-be39-5a74-8adf-44beac90510f","slug":"update","fullItemName":"Update"}]},{"id":"a2422ca0-3b24-5c6e-81d8-07d257fdd44a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2753bf62-a22c-5fb2-936c-554ef07426d4","slug":"goals","fullItemName":"Goals"},{"id":"65f25469-16d4-5c7f-b7bc-a6698ca61164","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"52a827c5-48de-5c0c-8dce-6c7eeeab720d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"cd3e39be-06ce-5750-a1f7-cbc06bb58756","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"50c51a08-6607-5699-96a8-d66cb532d2c5","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"05dc5599-43b4-5340-841b-3b3208f4b947","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"1fd04fd1-0023-5c48-9785-d9a54c7e2eb0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"5a84982b-be4e-5901-a577-110f09001119","slug":"definition","fullItemName":"Definition"},{"id":"dab82422-38f4-5a30-b0db-ad2cbf33c2ab","slug":"prevalence-of-dyspnoea-in-palliative-care","fullItemName":"Prevalence of dyspnoea in palliative care"},{"id":"ea086054-ae8f-5666-9159-99b04676d230","slug":"causes-of-dyspnoea","fullItemName":"Causes of dyspnoea"},{"id":"c2601cd4-69b1-563f-870a-8110f4c24103","slug":"complications-of-dyspnoea","fullItemName":"Complications of dyspnoea"}]},{"id":"db288340-b73c-59b1-a8ba-4baec577b887","fullItemName":"Management","slug":"management","subChapters":[{"id":"62ed0387-08f9-5656-8079-a5fffee537f4","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"cdb4ccb3-9b96-5651-9950-6e2e0b8f4da0","slug":"symptomatic-treatment","fullItemName":"Scenario: Symptomatic treatment"},{"id":"5b9d65e3-1fc3-558d-a95e-5e4ff147c7d7","slug":"known-cause-of-dyspnoea","fullItemName":"Scenario: Known cause of dyspnoea"},{"id":"3b6b57e5-ba14-5311-bbf3-d996401c7dc6","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"},{"id":"9983f052-047c-5346-adfc-b741909ce269","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"08f118cb-d39f-532d-b39f-fa97739c656d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"22221f0a-e6f8-5976-bf6c-1024268816e0","slug":"oxygen","fullItemName":"Oxygen"},{"id":"25b01dc5-45e8-563d-872f-cfec63e33029","slug":"opioids","fullItemName":"Opioids"},{"id":"b7f561a2-0802-545a-b7d1-db218387a6e5","slug":"benzodiazepines","fullItemName":"Benzodiazepines"}]},{"id":"9f0bdd3b-82e3-5cbb-908f-d36a887457a8","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5c3c7cfe-04b9-5ac4-9255-be56a20c7b5c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3aa322d7-2279-512c-93a7-55426d21da21","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b889ecee-814d-5e79-b596-a024fbee0acf","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7e27fb69-52fd-5ddc-8f84-6164bb8615d0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c1800f44-6de2-534a-a4ff-32b8b5cf6e24","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6b7633c0-45a5-5a2e-b564-f185c2b9ef5f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2d28faa0-4a5f-565b-a431-6339d01f6e91","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"db288340-b73c-59b1-a8ba-4baec577b887","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"6e343827-68fe-5162-925c-460ed0015bc6","slug":"simple-measures-to-help-dyspnoea","fullItemName":"Simple measures to help dyspnoea","depth":3,"htmlHeader":"<!-- begin field dbe5ec5c-47bf-4477-9694-924399f66aa7 --><h3>What simple measures may help dyspnoea in palliative care?</h3><!-- end field dbe5ec5c-47bf-4477-9694-924399f66aa7 -->","summary":null,"htmlStringContent":"<!-- begin item 0b94bbe0-5faa-4d96-8438-6b9211f72fb0 --><!-- begin field 7fa681cf-d897-44c1-b534-96784a8d5d89 --><ul><li><strong>Keep the room cool, improve air circulation with a fan or open window, and encourage relaxation and breathing techniques.</strong><ul><li>Controlled breathing techniques include positioning, pursed-lip breathing, breathing exercises, and coordinated breathing training.<ul><li>In pursed-lip breathing, people inhale through their nose for several seconds with their mouth closed, then exhale slowly through pursed lips for 4–6 seconds. This can help to relieve perception of dyspnoea during exercise or whenever dyspnoea is triggered.</li><li>Relaxing and dropping the shoulders reduces the 'hunched' posture that comes with anxiety.</li><li>Sitting upright increases peak ventilation and reduces airway obstruction.</li><li>Leaning forward with arms bracing a chair or knees with the upper body supported has been shown to improve ventilatory capacity.</li><li>Breathing retraining aims to help the person regain a sense of control and improve respiratory muscle strength. It is facilitated by physiotherapists and clinical nurse specialists.</li></ul></li></ul></li><li><strong>Provide reassurance and an explanation of dyspnoea and its underlying cause.</strong></li><li><strong>Encourage exercise within the person's capabilities. </strong>Exertion to the point of breathlessness can increase tolerance and maintain fitness. The level of physical activity that is realistically achievable will vary from person to person. For example, people with very limited mobility may be able to stand up only once every hour or move their feet a few times an hour.</li><li><strong>Discuss adaptations in activities of daily living and lifestyle expectations and involve other professionals to identify where additional support is required</strong>:<ul><li>Help the person adapt to their new respiratory capacity (for example review demands on mobility).</li><li>Suggest pacing of activities by doing the same things, but at a much slower rate.</li><li>Offer access to patient groups, day care facilities, and respite admissions, depending on the needs of the person and their family.</li></ul></li><li><strong>Consider management of other physical symptoms and the general psychological, social, and spiritual needs of the person and their family. </strong>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative cancer care - general issues</a>.</li></ul><!-- end field 7fa681cf-d897-44c1-b534-96784a8d5d89 --><!-- end item 0b94bbe0-5faa-4d96-8438-6b9211f72fb0 -->","subChapters":[{"id":"b5105f4a-67f8-52fd-ba24-f03b85b35172","slug":"basis-for-recommendation-231","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 6567a328-5062-4049-9726-d6cbb2608846 --><h4>Basis for recommendation</h4><!-- end field 6567a328-5062-4049-9726-d6cbb2608846 -->","summary":null,"htmlStringContent":"<!-- begin item 23170ac1-d75f-47af-ba5d-638c6ce2d2f5 --><!-- begin field 704d916c-de60-4e1e-b628-d1af12d31774 --><p>These recommendations are based on palliative care guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">International Association for Hospice and Palliative Care, 2013</a>] and expert opinion from the palliative care literature [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Davis, 1997</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Booth, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Booth and Dudgeon, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Twycross et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Chan, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Regnard, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Thomas et al, 2011</a>].</p><!-- end field 704d916c-de60-4e1e-b628-d1af12d31774 --><!-- end item 23170ac1-d75f-47af-ba5d-638c6ce2d2f5 -->","subChapters":[]}]},{"id":"d7b6b304-58cc-5869-8211-49db1c5eda7d","slug":"when-to-consider-an-opioid","fullItemName":"When to consider an opioid","depth":3,"htmlHeader":"<!-- begin field 58e6bf01-268c-44e2-8411-b09b5ffb140f --><h3>When should an opioid be considered?</h3><!-- end field 58e6bf01-268c-44e2-8411-b09b5ffb140f -->","summary":null,"htmlStringContent":"<!-- begin item 9c95e3ee-8b8a-41eb-960e-9d9e5e3cba44 --><!-- begin field b45ef73f-4a19-4992-8204-a7fe1fed34a0 --><ul><li>Consider using a strong opioid in people who need symptomatic treatment of dyspnoea, especially those with shortness of breath who are near the end of life.</li><li>Continue with non-pharmacological strategies when initiating an opioid. See <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/management/symptomatic-treatment/#simple-measures-to-help-dyspnoea\">Simple measures to help dyspnoea</a>.</li><li>Immediate-release oral morphine is the usual opioid of choice:<ul><li>Other routes of administration may be considered, but use of nebulized opioids is not recommended for symptomatic relief of breathlessness.</li><li>Intermittent opioid dosing is appropriate if dyspnoea is not continuous.</li><li>If the person cannot take oral medication, use a subcutaneous bolus of morphine or diamorphine when required or a subcutaneous continuous infusion of morphine or diamorphine delivered through a syringe driver.</li></ul></li><li>Concomitant use of an anti-emetic should be considered and treatment with regular laxatives commenced.</li><li>For more information see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/prescribing-information/opioids/\">opioids</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/prescribing-information/\">Prescribing information</a>.</li></ul><!-- end field b45ef73f-4a19-4992-8204-a7fe1fed34a0 --><!-- end item 9c95e3ee-8b8a-41eb-960e-9d9e5e3cba44 -->","subChapters":[{"id":"9700d412-c647-5095-a174-212ad4fe2193","slug":"basis-for-recommendation-a8b","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a102748c-46d7-4f15-82c1-02b0a677de75 --><h4>Basis for recommendation</h4><!-- end field a102748c-46d7-4f15-82c1-02b0a677de75 -->","summary":null,"htmlStringContent":"<!-- begin item a8b07a62-81da-4a84-aa8b-2f00da60efce --><!-- begin field d46b7ec3-9c2b-429e-8552-9379933436b0 --><p>These recommendations are based on palliative care guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHMRC, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHS Scotland, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHS Lothian, 2010</a>] and expert opinion from the palliative care literature [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Booth, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Chan, 2015</a>].</p><ul><li>Opioids can influence a person's perception of dyspnoea, and central mediation of breathing occurs in the brainstem respiratory centre, an area rich with opioid receptors [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Booth and Dudgeon, 2006</a>].<ul><li>On systematic review identified eight randomized controlled trials of the use of opioids on cancer-related dyspnoea (most of the trial participants had lung cancer or lung metastases). A meta-analysis done on three of the trials (n = 69) found a positive effect of opioid use on dyspnoea in either opioid-naive or opioid-tolerant people (WMD –1.31 [95% CI –2.49 to –0.13]) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Ben-Aharon et al, 2012</a>].</li><li>Expert opinion suggests that the oral or subcutaneous routes of administration are preferred when using opioids for the control of dyspnoea in palliative care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Cheung and Zimmermann, 2011</a>].</li></ul></li></ul><!-- end field d46b7ec3-9c2b-429e-8552-9379933436b0 --><!-- end item a8b07a62-81da-4a84-aa8b-2f00da60efce -->","subChapters":[]}]},{"id":"7cd9aa0d-a461-5920-b66a-a6ac6c51e89d","slug":"when-to-consider-benzodiazepines","fullItemName":"When to consider benzodiazepines","depth":3,"htmlHeader":"<!-- begin field f9e31462-80de-4b73-a405-71344e17844f --><h3>When should benzodiazepines be considered?</h3><!-- end field f9e31462-80de-4b73-a405-71344e17844f -->","summary":null,"htmlStringContent":"<!-- begin item da828486-a54d-4416-a1c9-1f28098a6d95 --><!-- begin field 67f7ee95-dc56-491d-b0af-16beb6188257 --><ul><li>Anxiolytics can relieve dyspnoea by depressing hypoxic or hypercapnic ventilatory responses and altering the emotional response to dyspnoea.</li><li>Consider short-term use of a benzodiazepine:<ul><li>If dyspnoea is associated with acute anxiety and benefit from <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/management/symptomatic-treatment/#simple-measures-to-help-dyspnoea\">simple measures</a> and an <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/management/symptomatic-treatment/#when-to-consider-an-opioid\">opioid</a> has been insufficient. Note that anxiety may contribute to, or result from, dyspnoea.</li><li>At the end of life.</li></ul></li><li>Benzodiazepine selection depends on the stage of terminal disease, the severity of anxiety, and the desired onset of action. For more information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/prescribing-information/benzodiazepines/\">benzodiazepines</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/prescribing-information/\">Prescribing information</a>.</li><li>In people at the end of life or those with severe anxiety, combining an oral opioid and benzodiazepine treatment may be beneficial, but monitoring for sedation is necessary.</li></ul><!-- end field 67f7ee95-dc56-491d-b0af-16beb6188257 --><!-- end item da828486-a54d-4416-a1c9-1f28098a6d95 -->","subChapters":[{"id":"33ef0e16-6a44-5820-b1f6-067015fd14c1","slug":"basis-for-recommendation-e5f","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 73714c4d-21b0-4613-b0e4-06d71af54ad8 --><h4>Basis for recommendation</h4><!-- end field 73714c4d-21b0-4613-b0e4-06d71af54ad8 -->","summary":null,"htmlStringContent":"<!-- begin item e5f5c1f8-3160-4b91-9184-e062e29e2cef --><!-- begin field 2748fcab-7d7f-48f3-8fac-cff7d3772efd --><p>These recommendations are based on palliative care guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">International Association for Hospice and Palliative Care, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHMRC, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHS Scotland, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NCCN, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHS Lothian, 2010</a>].</p><ul><li>Anxiety and agitation are often associated with dyspnoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHMRC, 2004</a>]. Evidence is insufficient to support the use of benzodiazepines in people with advanced cancer who have dyspnoea. Nonetheless, experts often recommend benzodiazepines to help relieve anxiety, and a trial of a benzodiazepine may be considered on an individual basis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHMRC, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Booth, 2006</a>].</li><li>A Cochrane systematic review (search date September 2009) included trials of the use of benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases (such as chronic obstructive pulmonary disease, chronic heart failure, motor neurone disease, and idiopathic pulmonary fibrosis) in adults [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Simon et al, 2010</a>].<ul><li>The seven studies included (n = 200) did not find evidence of a significant beneficial effect of benzodiazepines for the relief of breathlessness at rest, although there was a slight, non-significant trend towards a beneficial effect. Adverse effects of benzodiazepines such as drowsiness (more than placebo, but less than morphine) were also noted.</li><li>The authors of the Cochrane systematic review recommended that the use of benzodiazepines can be considered as a second- or third-line option when non-pharmacological measures and opioids have not been sufficiently effective in controlling dyspnoea. This is consistent with a recommendation in a guideline from NHS Lothian: <em>Breathlessness in Palliative Care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NHS Lothian, 2010</a>].</li></ul></li><li>A subsequent systematic review highlighted the lack of data to support the use of benzodiazepines specifically for cancer-related dyspnoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Ben-Aharon et al, 2012</a>].</li></ul><!-- end field 2748fcab-7d7f-48f3-8fac-cff7d3772efd --><!-- end item e5f5c1f8-3160-4b91-9184-e062e29e2cef -->","subChapters":[]}]},{"id":"6abf0449-991b-5dcc-873c-285a52ca0523","slug":"when-to-consider-corticosteroids","fullItemName":"When to consider corticosteroids","depth":3,"htmlHeader":"<!-- begin field 48f0571e-3cf2-4757-a213-b3af5cdd6fe3 --><h3>When should corticosteroids be considered?</h3><!-- end field 48f0571e-3cf2-4757-a213-b3af5cdd6fe3 -->","summary":null,"htmlStringContent":"<!-- begin item 0827556f-3a13-44f1-88dc-2fb3a69a2896 --><!-- begin field 07179465-3d70-4e30-837a-a9ad8ee8d011 --><ul><li>Corticosteroids may be necessary in emergency situations involving airway obstruction (see <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/management/known-cause-of-dyspnoea/\">Scenario: Known cause of dyspnoea</a>), but otherwise should ideally be initiated only by, or on the advice of, a specialist.</li><li>However, if specialist advice is not available when needed, the decision should be based on the cause of the breathlessness, the likelihood of benefit, and the risk of adverse effects. Local guidelines should be followed, the person should be closely monitored, and specialist advice should be sought as soon as possible with early review by a specialist.</li></ul><!-- end field 07179465-3d70-4e30-837a-a9ad8ee8d011 --><!-- end item 0827556f-3a13-44f1-88dc-2fb3a69a2896 -->","subChapters":[{"id":"ac3f645c-1b1c-5be8-aa12-0546a5604bac","slug":"basis-for-recommendation-a0b","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 8b0c0736-e8dd-4fca-a8cb-f7cf61ec927f --><h4>Basis for recommendation</h4><!-- end field 8b0c0736-e8dd-4fca-a8cb-f7cf61ec927f -->","summary":null,"htmlStringContent":"<!-- begin item a0baa471-4a78-4091-b6ab-4084cc1d0986 --><!-- begin field 292f9164-acc4-4981-9b7f-ce98136a522d --><p>These recommendations are pragmatic advice, based on expert opinion from medical and palliative care specialist reviewers of this CKS topic.</p><!-- end field 292f9164-acc4-4981-9b7f-ce98136a522d --><!-- end item a0baa471-4a78-4091-b6ab-4084cc1d0986 -->","subChapters":[]}]},{"id":"8671a5c7-1a2f-5a7f-b9fe-816526177355","slug":"when-to-consider-bronchodilators","fullItemName":"When to consider bronchodilators","depth":3,"htmlHeader":"<!-- begin field c0813e0b-d8fe-4ea2-80b6-b6510a83a373 --><h3>When should bronchodilators be considered?</h3><!-- end field c0813e0b-d8fe-4ea2-80b6-b6510a83a373 -->","summary":null,"htmlStringContent":"<!-- begin item 45e4baef-78a2-4eaa-a7f0-eb1f52cc7962 --><!-- begin field afa69434-6ca3-440f-9be6-26f182df278f --><ul><li>If a person has wheeze thought to be caused by partial airway obstruction from a tumour:<ul><li>Refer for more definitive treatment (for example radiotherapy or stenting), if appropriate to the person's stage of illness. Seek specialist advice if unsure.</li><li>If more definitive treatment is not appropriate, or the person has to wait for treatment, consider a trial of bronchodilator while waiting, and assess benefit.<ul><li>If nebulized bronchodilator is used, monitor for adverse effects, such as bronchospasm, after the first dose.</li></ul></li></ul></li><li>For emergency management of severe airway obstruction, see <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/management/known-cause-of-dyspnoea/#managing-dyspnoea-of-known-cause\">Managing dyspnoea of known cause</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/management/known-cause-of-dyspnoea/\">Scenario: Known cause of dyspnoea</a>.</li></ul><!-- end field afa69434-6ca3-440f-9be6-26f182df278f --><!-- end item 45e4baef-78a2-4eaa-a7f0-eb1f52cc7962 -->","subChapters":[{"id":"628330f1-46eb-5c7d-a31a-ea0063ac5036","slug":"basis-for-recommendation-f0a","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 84e3306b-8f07-4902-af63-a2b2f9bf4210 --><h4>Basis for recommendation</h4><!-- end field 84e3306b-8f07-4902-af63-a2b2f9bf4210 -->","summary":null,"htmlStringContent":"<!-- begin item f0a1d3fa-3eec-41ad-af04-93daa996efb7 --><!-- begin field e26d610d-2b22-4675-a068-58a54a1b5169 --><p>These recommendations are pragmatic advice, based on expert opinion from palliative care and medical specialist reviewers of this CKS topic.</p><!-- end field e26d610d-2b22-4675-a068-58a54a1b5169 --><!-- end item f0a1d3fa-3eec-41ad-af04-93daa996efb7 -->","subChapters":[]}]},{"id":"86ff8e57-7e41-5682-a277-0049072ba569","slug":"when-to-consider-oxygen","fullItemName":"When to consider oxygen","depth":3,"htmlHeader":"<!-- begin field e96197ca-e460-4527-ac43-fbaafd77ad00 --><h3>When should I consider oxygen therapy?</h3><!-- end field e96197ca-e460-4527-ac43-fbaafd77ad00 -->","summary":null,"htmlStringContent":"<!-- begin item 0a884553-dee5-4c20-bf52-b8b70ef35e3d --><!-- begin field b27accdb-a51a-45e1-86d0-351bcf522469 --><ul><li>Consider oxygen therapy in people with dyspnoea who are known or clinically suspected to have symptomatic hypoxaemia.</li><li>Consider non-pharmacological management of breathlessness in a person in the last days of life. Do not routinely start oxygen to manage breathlessness. Only offer oxygen therapy to people known or clinically suspected to have symptomatic hypoxaemia (SpO<sub>2</sub> less than or equal to 92%).</li><li>Consider managing breathlessness with:<ul><li>An opioid <strong>or</strong></li><li>A benzodiazepine <strong>or</strong></li><li>A combination of an opioid and benzodiazepine.</li></ul></li><li>When selecting people for oxygen therapy, carefully consider the potential <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/prescribing-information/oxygen/#adverse-effects\">risks</a> and benefits in each case.</li><li>A trial of short-burst oxygen therapy may be initiated in primary care if considered appropriate following assessment (preferably after discussion with a specialist), and should be tailored to a person's needs.<ul><li>Little evidence supports the use of short-burst oxygen therapy immediately before and after exercise.</li><li>However, expert opinion suggests that short-burst oxygen therapy may also be useful for pre-planned activity which triggers breathlessness (such as washing).</li><li>Short-burst oxygen therapy should be initiated at 2 L/minute. Some experts suggest an initial duration of treatment of between 15 and 30 minutes, but other experts suggest continuing until the person feels benefit.</li></ul></li><li>Long-term oxygen therapy (15 hours or more a day) should be initiated by a respiratory specialist for people with severe disabling breathlessness due to cancer or other progressive, life-threatening diseases.</li><li>Oxygen therapy may also be appropriate in people with cancer who have dyspnoea of non-malignant causes. For more information, see <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/management/known-cause-of-dyspnoea/\">Scenario: Known cause of dyspnoea</a>.</li><li>For more information see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/prescribing-information/oxygen/\">oxygen</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/prescribing-information/\">Prescribing information</a>.</li></ul><!-- end field b27accdb-a51a-45e1-86d0-351bcf522469 --><!-- end item 0a884553-dee5-4c20-bf52-b8b70ef35e3d -->","subChapters":[{"id":"01ae1870-3750-5b97-9474-1b72979bb635","slug":"basis-for-recommendation-919","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 81f00f7c-cba8-4952-b725-9458bada63b9 --><h4>Basis for recommendation</h4><!-- end field 81f00f7c-cba8-4952-b725-9458bada63b9 -->","summary":null,"htmlStringContent":"<!-- begin item 919fb8da-98fa-480c-a78b-d14152c11118 --><!-- begin field fd92e89d-8e50-48d9-9ccd-fbd7eaad4b0c --><p>Appropriate use of oxygen therapy is recommended for some people with dyspnoea and cancer in palliative care guidelines including the <em>BTS guidelines for home oxygen use in adults</em>, [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Hardinge, 2015</a>], National Institute for Health and Care Excellence guideline <em>Care of dying adults in the last days of life </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">NICE, 2015a</a>], Scottish Palliative Care Guidelines on <em>Breathlessness</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Scottish Palliative Care Guidelines, 2015</a>], North of England Cancer Network guidance on <em>Palliative and end of life care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Northern England Clinical Networks, 2016</a>], and palliative care literature [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Twycross, 2014</a>]. Recommendations were also based on the expert opinion of palliative care specialists.</p><ul><li>It is recognised that oxygenation levels need to be assessed to measure people with dyspnoea who are also suffering from hypoxaemia. A pulse oximeter may help identify those patients who will require formal blood gas measurement but cannot be solely relied upon for an accurate blood oxygen assessment. However, CKS recognises that measurement of arterial blood gases may be impractical and challenging in the palliative care setting. The British Thoracic Society guidelines on oxygen therapy recommend that people who may be severely hypoxaemic and benefit from sufficient oxygen to achieve an SpO<sub>2 </sub>of more than 92% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Hardinge, 2015</a>]. However, they also recommend that 'hypoxaemia should be assessed using an objective measurement of oxygenation (for example arterial or capillary blood gases).' CKS recommends that clinical judgement should be used in conjunction with advice from specialists in palliative care and respiratory medicine when considering the prescription of oxygen for dyspnoea in palliative care. </li><li>In people with oxygen saturation greater than 92%, the role of oxygen is controversial because studies of this group have found no significant difference in benefit provided by nasal prongs delivering piped air or oxygen [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-dyspnoea/references/\">Twycross, 2014</a>]. </li><li>It is very difficult to select people who will benefit significantly from oxygen therapy as there is often an inconsistent relationship between hypoxaemia, dyspnoea and response to oxygen therapy. </li></ul><!-- end field fd92e89d-8e50-48d9-9ccd-fbd7eaad4b0c --><!-- end item 919fb8da-98fa-480c-a78b-d14152c11118 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}